EICHOR
● Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Condition: Advanced or Metastatic Solid Tumors · Sponsor: DynamiCure Biotechnology
About this study
This is a multicenter, open-label, Phase 1 study to assess the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or metastatic solid tumors. The study consists of an Escalation Phase (Phase 1a) and a Dose Expansion/Optimization Phase (Phase 1b).
This description comes directly from the study's public registry record.
Talk to the study team
Sr Medical Director · +1 (781) 373-9136 · alejandrogomez@dynamicure.com
Always discuss trial participation with your own doctor first.
Locations (35)
| University of Alabama | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic | Phoenix, Arizona, United States | Recruiting |
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| Sarah Cannon Research Institute Denver Healthone | Denver, Colorado, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| Mayo Clinic | Jacksonville, Florida, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| John Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore, Maryland, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Completed |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| MonteFiore | The Bronx, New York, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05785754